Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Neoplasms × Tea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Prostatic Neoplasms 10 Lung Neoplasms 4 Pancreatic Neoplasms 3 Pain, Postoperative 3 Colonic Neoplasms 3 Urinary Bladder Neoplasms 2 Male Urogenital Diseases 2 Leiomyoma 2 Inflammation 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Stomatitis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Skin Neoplasms 1 Shoulder Pain 1 Psychological Well-Being 1 Postoperative Complications 1 Post-thoracotomy Pain Syndrome 1 Neoplasms 1 Mouth Neoplasms 1 Motor Activity 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Follicular 1 Lung Cancer Prevention 1 Liver Neoplasms 1 Inflammatory Bowel Diseases 1

Interventions

pembrolizumab 146 Gemcitabine 134 Paclitaxel 126 Carboplatin 116 Bevacizumab 108 Docetaxel 94 Cyclophosphamide 93 Cisplatin 92 Exercise 78 Nivolumab 77 Fluorouracil 73 Capecitabine 72 Dexamethasone 70 Irinotecan 62 Radiotherapy 57 Pemetrexed 57 Oxaliplatin 57 Standard of Care 55 Leucovorin 53 Cetuximab 47 Drug Therapy 45 Sorafenib 44 Erlotinib Hydrochloride 44 Doxorubicin 41 atezolizumab 40 Blood Specimen Collection 40 130-nm albumin-bound paclitaxel 37 trametinib 34 Ipilimumab 34 venetoclax 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01162642 2015-04-21

Green Tea Anticancer Mechanisms in Smokers

Ohio State University

Phase NA Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡